Yanlin Wu

888 total citations · 2 hit papers
11 papers, 578 citations indexed

About

Yanlin Wu is a scholar working on Molecular Biology, Cancer Research and Public Health, Environmental and Occupational Health. According to data from OpenAlex, Yanlin Wu has authored 11 papers receiving a total of 578 indexed citations (citations by other indexed papers that have themselves been cited), including 5 papers in Molecular Biology, 3 papers in Cancer Research and 2 papers in Public Health, Environmental and Occupational Health. Recurrent topics in Yanlin Wu's work include MicroRNA in disease regulation (2 papers), RNA modifications and cancer (2 papers) and Extracellular vesicles in disease (2 papers). Yanlin Wu is often cited by papers focused on MicroRNA in disease regulation (2 papers), RNA modifications and cancer (2 papers) and Extracellular vesicles in disease (2 papers). Yanlin Wu collaborates with scholars based in China and United States. Yanlin Wu's co-authors include Zhihong Li, Zhengjun Lin, Guoqing Li, Tang Liu, Xiao Lin, Fu‐Xing‐Zi Li, Bei Guo, Changchun Li, Ming-Hui Zheng and Ling‐Qing Yuan and has published in prestigious journals such as JNCI Journal of the National Cancer Institute, Scientific Reports and Journal of Bone and Mineral Research.

In The Last Decade

Yanlin Wu

11 papers receiving 572 citations

Hit Papers

Epigenetic regulation in metabolic diseases: mechanisms a... 2022 2026 2023 2024 2023 2022 50 100 150 200

Peers

Yanlin Wu
Guihai Ai China
Jun Shi China
Wen Du China
Guihai Ai China
Yanlin Wu
Citations per year, relative to Yanlin Wu Yanlin Wu (= 1×) peers Guihai Ai

Countries citing papers authored by Yanlin Wu

Since Specialization
Citations

This map shows the geographic impact of Yanlin Wu's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Yanlin Wu with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Yanlin Wu more than expected).

Fields of papers citing papers by Yanlin Wu

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Yanlin Wu. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Yanlin Wu. The network helps show where Yanlin Wu may publish in the future.

Co-authorship network of co-authors of Yanlin Wu

This figure shows the co-authorship network connecting the top 25 collaborators of Yanlin Wu. A scholar is included among the top collaborators of Yanlin Wu based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Yanlin Wu. Yanlin Wu is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

11 of 11 papers shown
1.
Wu, Yanlin, Shaogui Wan, Long Yi, et al.. (2024). Correlation between circulating cell-free mitochondrial DNA content and severity of knee degeneration in patients with knee osteoarthritis: a cross-sectional study. Arthritis Research & Therapy. 26(1). 202–202. 3 indexed citations
3.
Wu, Yanlin, et al.. (2024). Effects of foot reflexology massage on pregnant women: a systematic review and meta-analysis of randomized controlled studies. Scientific Reports. 14(1). 1012–1012. 5 indexed citations
4.
Zhou, Yong, Feng Xu, Xiao Lin, et al.. (2024). Assessment of causal association between the socio-economic status and osteoporosis and fractures: a bidirectional Mendelian randomization study in European population. Journal of Bone and Mineral Research. 39(7). 942–955. 3 indexed citations
5.
Ye, Hua, et al.. (2023). Effects of rapeseed oil on body composition and glucolipid metabolism in people with obesity and overweight: a systematic review and meta-analysis. European Journal of Clinical Nutrition. 78(1). 6–18. 6 indexed citations
6.
Wu, Yanlin, Zhengjun Lin, Changchun Li, et al.. (2023). Epigenetic regulation in metabolic diseases: mechanisms and advances in clinical study. Signal Transduction and Targeted Therapy. 8(1). 98–98. 222 indexed citations breakdown →
7.
Lin, Zhengjun, Jian Zhou, Guoqing Li, et al.. (2023). Exosomal circRNAs in cancer: Implications for therapy resistance and biomarkers. Cancer Letters. 566. 216245–216245. 43 indexed citations
8.
Wu, Yanlin, et al.. (2023). Ferroptosis-related gene HIC1 in the prediction of the prognosis and immunotherapeutic efficacy with immunological activity. Frontiers in Immunology. 14. 1182030–1182030. 9 indexed citations
9.
Lin, Zhengjun, et al.. (2022). Mesenchymal stem cell-derived exosomes in cancer therapy resistance: recent advances and therapeutic potential. Molecular Cancer. 21(1). 179–179. 197 indexed citations breakdown →
10.
Gao, Jing, Jian Li, Yating An, et al.. (2014). Increasing effect of Tangzhiqing formula on IRS-1-dependent PI3K/AKT signaling in muscle. BMC Complementary and Alternative Medicine. 14(1). 198–198. 28 indexed citations
11.
Ai, Jing, Qingjuan Tang, Yanlin Wu, et al.. (2011). The Role of Polymeric Immunoglobulin Receptor in Inflammation-Induced Tumor Metastasis of Human Hepatocellular Carcinoma. JNCI Journal of the National Cancer Institute. 103(22). 1696–1712. 60 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026